Peng Yifei, General Manager of Tigermed捷通, Confirms Participation in the 3rd International Medical Device Innovation Summit
In the fields of in vitro diagnostics, high-value consumables, and rehabilitation equipment, how can the right development path be identified through upstream-downstream supply chain collaboration, upgrading of technological and industrial foundations, and integrated coordination of key industry development factors?June 22, 2021，2021 The 3rd International Summit on Medical Device Innovationwill be held onChina · Nanjingheld. This event will focus on“Intelligent Manufacturing as the Foundation, Collaborative Innovation”Centered on this theme, the event will bring together the most dynamic medical device innovation companies, listed firms, financial institutions, and healthcare organizations from China and abroad through activities such as the Medical Device Vitality Rankings, closed-door government-enterprise meetings, overseas live connections, keynote speeches, and pioneer dialogues, creating a premier offline summit for the medical device industry.
This event is hosted by the Nanjing New Medicine and Life Health Industry Chain Working Task Force and the People's Government of Gaochun District, Nanjing; organized by the Office of the Innovation Committee of the CPC Gaochun District Committee and VCBeat; and co-organized by Jiangsu Gaochun Economic Development Zone and Jiangsu Gaochun High-Tech Industrial Development Zone.
Peng Yifei, General Manager of Tigermed JietongConfirmed participation in the 3rd International Summit on Medical Device Innovation, where relevant insights will be shared.
Click the image to register
Peng Yifei,General Manager of Tigermed Jietong
Peng Yifei,General Manager of Tigermed Jietong. Fully responsible for medical device-related services under Tigermed. Has held management positions in Chinese and foreign enterprises across biomedical R&D and manufacturing, pharmaceutical product investment and management, medical device registration, and clinical trials for drugs and medical devices. Possesses profound expertise in the translation of Chinese pharmaceutical products, as well as in the management and registration of medical device clinical trials. Holds a Master’s degree in Biochemistry from East China Normal University, is a licensed pharmacist, and serves as a specially appointed expert of the Clinical Trial Branch of the China Association for Medical Devices Industry. Brings nearly 20 years of practical experience in the pharmaceutical and healthcare sector.
Tigermed Jietong, a wholly-owned subsidiary of Tigermed, was established in 2000. As a leading Chinese contract research organization (CRO) specializing in regulatory affairs and clinical studies for medical devices (including in vitro diagnostic products), it provides comprehensive lifecycle coverage across all sectors of the medical device industry. Over the past two decades, Tigermed Jietong has built long-term partnerships with more than 1,700 medical device R&D and manufacturing enterprises from over 30 countries. Leveraging its professional service capabilities, the company helps clients mitigate registration risks, shorten project timelines, reduce R&D costs, and accelerate product commercialization.
At the summit, we have specially invitedNobel Laureate in Physiology or Medicine, Academician of the Chinese Academy of Sciences and the Chinese Academy of EngineeringRenowned experts will share cutting-edge technologies and frontier medical advancements from both China and abroad, focusing on medical development amidst technological transformation, and redefining the evolutionary logic of technology and innovative thinking in the industry.
Senior executives from leading medical device companies, outstanding innovative entrepreneurs, senior directors of innovation departments, and seasoned investors will focus on “"Post-Pandemic Growth Curve of the IVD Industry," "High-Value Consumables Under Domestic Substitution and Volume-Based Procurement," "Innovation in Rehabilitation Products and Application Scenarios Amid an Aging Population"Conduct in-depth discussions along three main lines.
Currently,Edvard Moser, Winner of the 2014 Nobel Prize in Physiology or MedicineConfirmed participation in this event, and will deliver a presentation on “How the Brain Works: A Spatial Systems Approach to Decoding Computation in the Brain.”Academician of the Chinese Academy of Sciences and neurosurgery expert Zhao Jizong, and Academician of the Chinese Academy of Engineering Zhang ZhiyuanAll have confirmed their attendance and will deliver relevant presentations.
The 2021 List of Innovative Vitality in Medical Devices is part of the regular series of the Future Healthcare Top 100. VCBeat, with industrial research as its foundation, focuses on innovative development, technological transformation, and policy iterations in the medical device sector, while identifying high-growth innovative medical device companies fromIn Vitro Diagnostics (Digital PCR Category)、High-Value Consumables (Cardiovascular Intervention)、Rehabilitation Equipment (Rehabilitation Robotics)The rankings across three fundamental dimensions, along with the “Black Tech” in Medical Devices ranking, selected the 2021 Enterprises with Innovative Vitality in the Medical Device Industry.
The 2021 Medical Device Innovation Vitality Ranking will be announced at the 3rd International Summit on Medical Device Innovation in 2021., and will be disseminated and promoted through VCBeat’s online media matrix.
Edward Mosol, 2014 Nobel Prize in Physiology or Medicine
Zhao Jizong, Academician of the Chinese Academy of Sciences and Neurosurgeon
Zhang Zhiyuan, Academician of the Chinese Academy of Engineering
Deng Jianmin, Senior Vice President of BD Worldwide and General Manager of Greater China
Kang Keren, Senior Vice President of Wondfo Biotech
Shen Qin, Partner at Shengyu Investment
Guo Feng, Founder of Zhenzhun Biology
Peng Yifei, General Manager of Tigermed Jietong
Jin Lei, CEO of BaiRen Medical
Wang Jinhe, Vice President of Johnson & Johnson MedTech
Yang Zhihao, Vice President of Fourier Intelligence
Xu Junhua, Founder of Aomei Health
More speakers to be confirmed...
Proposed Schedule
You’re Just One Ticket Away from Industry Titans
Time:Tuesday, June 22, 2021
Location:China · Nanjing
Registration Link:https://5332500000796.huodongxing.com/event/2597428453800
Click the image above or scan the QR code to register for free